Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Ovarian Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Cholangiocarcinoma 4Small Cell Lung Carcinoma 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Neuroblastoma 3Lung Neoplasms 3Gallbladder Neoplasms 3Fallopian Tube Neoplasms 3Stomach Neoplasms 2Mesothelioma, Malignant 2Klatskin Tumor 2Ganglioneuroblastoma 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Seminoma 1Sarcoma 1Pinealoma 1Peritoneal Neoplasms 1

Interventions

pazopanib 3Erlotinib Hydrochloride 3Cetuximab 3Vorinostat 2Oxaliplatin 2Bevacizumab 2Azacitidine 2satraplatin 1ixazomib 1X-Rays 1Valproic Acid 1Trastuzumab 1Sorafenib 1Platinum 1Pemetrexed 1Magnetic Resonance Spectroscopy 1Leucovorin 1Lenalidomide 1Lapatinib 1LY 2275796 1Injections, Subcutaneous 1Fluorouracil 1Everolimus 1Curcumin 1Crizotinib 1Capecitabine 1Albumin-Bound Paclitaxel 1AH 111585 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Advanced Cancers × Platinum × Clear all
NCT00473720 2013-01-23

Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers

Yale University

Phase 1 Completed
15 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡